Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resistance prediction in high-grade serous ovarian carcinoma with neoadjuvant chemotherapy using data-independent acquisition proteomics and an ovary-specific spectral library. | Mol Oncol | 2023 | 36855266 | PubTator, text mining | PubMed |
| Co-translational Installation of Posttranslational Modifications by Non-canonical Amino Acid Mutagenesis. | Chembiochem | 2023 | 36853967 | PubTator, text mining | PubMed |
| The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors. | Molecules | 2023 | 36838960 | PubTator, text mining | PubMed |
| HDAC8 Deacetylates HIF-1α and Enhances Its Protein Stability to Promote Tumor Growth and Migration in Melanoma. | Cancers (Basel) | 2023 | 36831463 | PubTator, text mining | PubMed |
| The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells. | Cancers (Basel) | 2023 | 36831382 | PubTator, text mining | PubMed |
| DDX47, MeCP2, and other functionally heterogeneous factors protect cells from harmful R loops. | Cell Rep | 2023 | 36827184 | PubTator, text mining | PubMed |
| Enzyme Inhibitors from Gorgonians and Soft Corals. | Mar Drugs | 2023 | 36827145 | PubTator, text mining | PubMed |
| LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials. | Front Pharmacol | 2023 | 36817147 | PubTator, text mining | PubMed |
| Rare diseases of epigenetic origin: Challenges and opportunities. | Front Genet | 2023 | 36814905 | PubTator, text mining | PubMed |
| Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma. | Biomed Res Int | 2023 | 36814797 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Breast Cancer: Insights on Epidrugs. | Epigenomes | 2023 | 36810560 | PubTator, text mining | PubMed |
| Modulating epigenetic modifications for cancer therapy (Review). | Oncol Rep | 2023 | 36799181 | PubTator, text mining | PubMed |
| Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. | Signal Transduct Target Ther | 2023 | 36797244 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and immune infiltration characteristics in recurrent implantation failure using bioinformatics analysis. | Front Immunol | 2023 | 36776897 | PubTator, text mining | PubMed |
| Epigenetic mechanisms of Immune remodeling in sepsis: targeting histone modification. | Cell Death Dis | 2023 | 36774341 | PubTator, text mining | PubMed |
| HDAC8 regulates protein kinase D phosphorylation in skeletal myoblasts in response to stress signaling. | Biochem Biophys Res Commun | 2023 | 36773343 | PubTator, text mining | PubMed |
| PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities. | Molecules | 2023 | 36770884 | PubTator, text mining | PubMed |
| Immunological evaluation of young unvaccinated patients with Turner syndrome after COVID-19. | Int J Infect Dis | 2023 | 36758851 | PubTator, text mining | PubMed |
| The main protease of SARS-CoV-2 cleaves histone deacetylases and DCP1A, attenuating the immune defense of the interferon-stimulated genes. | J Biol Chem | 2023 | 36758802 | PubTator, text mining | PubMed |
| Salivary histone deacetylase in periodontal disease: A cross-sectional pilot study. | J Periodontal Res | 2023 | 36717759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=23